26
views
0
recommends
+1 Recommend
3 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Long-Lasting COVID-Associated Brain Fog: A Follow-Up Study

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction: We investigated the longevity of COVID-associated brain fog in patients who have survived the COVID-19. Methods: This was a follow-up study of 2,696 adult patients with COVID-19 from our previous study. We selected every other patient in our database. The follow-up data were collected during a phone call to the participants in January–February 2022 (11 months after the initial study): concentration difficulty and the patient’s self-declared status in their ability to concentrate. Results: In total, 1,164 people were included; 35 people (3.0%) had concentration difficulty and 65 individuals (5.6%) had a worsened status in their ability to concentrate and think; 26 people (2.2%) responded yes to both questions and were considered as having long-lasting brain fog. People with long-lasting brain fog were more often admitted to ICUs during the initial hospitalization (23.1% vs. 9.3%; p = 0.032) compared with those without long-lasting brain fog. Conclusion: We may conclude that a minority of the hospitalized patients with COVID-19 may suffer from long-lasting post-COVID brain fog, at least for more than 1 year after their initial illness. Long-lasting post-COVID brain fog has a significant association with the severity of the initial illness.

          Related collections

          Author and article information

          Journal
          ENE
          Eur Neurol
          10.1159/issn.0014-3022
          European Neurology
          Eur Neurol
          S. Karger AG
          0014-3022
          1421-9913
          2023
          July 2023
          24 February 2023
          : 86
          : 3
          : 166-170
          Affiliations
          [_a] aEpilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
          [_b] bDepartment of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
          [_c] cCardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
          Author information
          https://orcid.org/0000-0002-2598-7601
          https://orcid.org/0000-0001-6453-2303
          https://orcid.org/0000-0003-0101-0780
          https://orcid.org/0000-0001-8969-7155
          Article
          529860 Eur Neurol 2023;86:166–170
          10.1159/000529860
          36843124
          8fd644f0-6784-4c29-b216-af9d36ec7537
          © 2023 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

          History
          : 23 April 2022
          : 16 February 2023
          Page count
          Tables: 1, Pages: 5
          Funding
          This research did not receive any grant from funding agencies in the public, commercial, or not-for-profit sectors.
          Categories
          Clinical Neurology: Research Article

          Medicine
          COVID-19,Coronavirus,Brain,SARS-CoV-2
          Medicine
          COVID-19, Coronavirus, Brain, SARS-CoV-2

          Comments

          Comment on this article